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Video laparoscopic intervention for an interstitial 
pregnancy after failure of clinical treatment
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aBstraCt
CONTEXT: Interstitial pregnancy is a rare form of ectopic pregnancy for which the best therapeutic 
course of action has yet to be determined. Surgical intervention entails a high risk of hemorrhage 
due to the great vascularization of the cornual region of the uterus. Case descriptions facilitate the 
analysis of results and aid clinicians in determining the most appropriate course of action in these 
situations.
CASE REPORT: In a patient with an ultrasound diagnosis of interstitial pregnancy, clinical treatment 
using methotrexate was chosen. However, after one week, there was a marked decline in the serum 
level of the β subunit of chorionic gonadotropin hormone, although an ultrasound examination re-
vealed embryonic cardiac activity. A second dose of the chemotherapy was administered. Embryonic 
cardiac activity persisted 48 hours later. Video laparoscopy was performed to achieve right-side cor-
nual resection, which resulted in satisfactory resolution of the case. 
resUMo
CONTEXTO: A gestação intersticial é uma forma rara de gestação ectópica. A melhor opção terapêu-
tica ainda não está definida, havendo risco de hemorragia com o tratamento cirúrgico, em decorrên-
cia da grande vascularização na região cornual uterina. A descrição de casos facilitam a análise dos 
resultados e ajuda os clínicos a determinarem a melhor conduta nessas situações.
RELATO DE CASO: Em paciente com diagnóstico ultrassonográfico de gestação intersticial, optou-se 
por tratamento clínico com administração de metotrexate. Após uma semana, houve declínio acen-
tuado do nível sérico da sub-unidade β do hormônio gonadotrófico coriônico, porém, na ultrasso-
nografia, foi detectada a presença de atividade cardíaca embrionária. Foi administrada uma segunda 
dose do quimioterápico. Após 48 horas, a atividade cardíaca persistia. Realizou-se vídeo-laparoscopia 
para ressecção cornual direita, com resolução satisfatória do caso.
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INTRODUCTION
Interstitial pregnancy is a rare form of ectopic pregnancy that occurs when a blastocyst 
implants between the ostium and the isthmic region of the fallopian tube, where the tube 
transverses the muscle wall of the uterus.1 Interstitial pregnancy should not be confused 
with cornual pregnancy, which develops in the horn of a bicornuate uterus.2 Interstitial 
pregnancy accounts for 2 to 4% of all ectopic pregnancies and has a mortality rate of 2.0 
to 2.5%. Accordingly, interstitial pregnancy is the main cause of maternal death in the 
first trimester of pregnancy, and its associated risks are approximately seven times greater 
than the risks of ectopic pregnancies in general.3-6 This high maternal mortality rate can 
be attributed to the possibility of rupture. If this occurs, it results in catastrophic hemor-
rhaging because of the extensive vascularization of the region.2 The treatment for inter-
stitial pregnancy remains controversial. Conservative treatment with methotrexate is an 
option for patients with a confirmed diagnosis who wish to preserve their reproductive 
function, provided that there has not been any occurrence of uterine rupture.7 Late diag-
nosis diminishes the viability of conservative treatment or minimally invasive surgery, 
and increases the maternal mortality risk.6,8 
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was 35.6. Her Hb and Ht levels were 11.1 g/dl and 34.7, one 
day after this procedure. No complications occurred, and the 
patient made a very good recovery. She was released two days 
after the procedure.
DISCUSSION
The isthmic portion of the fallopian tube, which transverses the 
uterine wall, is the segment that commences at the ostium of the 
fallopian tube and ascends laterally to the exterior of the uterus. 
It measures 0.7 mm in diameter and 2 cm in length, and is the 
region where the tube is enclosed by a thin film of uterine mus-
cle tissue. The anatomy of the isthmic portion of the fallopian 
tube is thought to enable greater expansion than is possible in 
other tubular regions. As a consequence, interstitial pregnancy 
can persist, in rare cases, asymptomatically for up to 16 weeks.1 
Figure 1. Gestational sac at time of diagnosis of interstitial pregnancy.
Figure 2. Embryonic cardiac activity in a case of interstitial pregnancy.
CASE REPORT
The patient was 33 years old and had a history of having deliv-
ered a baby by caesarian section 23 months before the proce-
dure reported here. Six months prior to that delivery, she had 
undergone laparoscopic myomectomy of the right cornual 
region, excision of ovarian cysts on the left side and resec-
tion of the terminal ileum, cecum and appendix because of 
endometriosis. The patient had not undergone any reproduc-
tive treatments. Given the characteristics of the case and the 
requirements under the code of conduct, the protocol did not 
require submission of this study to the ethics committee at 
Hospital Israelita Albert Einstein (HIAE).
The patient presented a five-day menstrual delay, 
β-fraction human chorionic gonadotropin (β-hCG) con-
centration of 11,631 mIU/ml, and did not show any clinical 
signs such as pelvic floor pain or vaginal bleeding. Transvagi-
nal ultrasonography revealed an empty uterine cavity and the 
presence of an oval entity between the endometrial cavity and 
the extrauterine tubular region. A thin rim of myometrial tis-
sue (cross-sectional area, 17 mm x 15 mm) encircling an echo-
genic center (11 mm x 4 mm x 9 mm) suggestive of a gesta-
tional sac with an interior vitelline vesicle 2.3 mm in diameter 
was observed (Figure 1), and Doppler velocimetry indicated 
peripheral flow. These findings corresponded to a gestation 
period of 5.5 weeks.
Serial measurements of serum β-hCG concentrations 
showed an increase to 21,281 mIU/ml, 48 hours later. In such 
cases, an intramuscular injection of methotrexate at a dos-
age of 50 mg/m2 of body surface area is recommended in the 
treatment protocols used for extrauterine pregnancies.7 In 
this case, a 96-mg dose, corresponding to the patient’s height 
of 1.76 m, was used. One week later, the patient’s serum 
β-hCG concentrations showed a significant decrease (to 
18,144 mIU/ml), and the patient remained asymptomatic. 
However, routine transvaginal ultrasonography revealed a 
small increase in the size of the gestational sac and embry-
onic cardiac activity (Figure 2).
Given the abovementioned findings, a decision was made 
to give a second intramuscular injection of methotrexate, 
with ultrasonographic control 48 hours later. The patient’s 
serum β-hCG concentrations continued to decrease (to 14,212 
mIU/ml), but embryonic vitality persisted. The gestational sac 
increased longitudinally in size, in the direction of the isthmic 
portion of the fallopian tube (Figure 3 and 4). After discuss-
ing the risks associated with progression of the gestational sac, 
such as rupture of the fallopian tube, the couple in question opted 
for video laparoscopy to resect the right-side section of the cornua 
(Figure 5). The procedure was completed without any complica-
tions or significant bleeding. The patient’s preoperative hemo-
globin (Hb) level was 11.5 g/dl and her hematocrit (Ht) level 
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Figure 3. Gestational sac next to endometrium in a case of interstitial 
pregnancy. White arrow shows the empty uterine cavity.
Figure 4. Gestational sac growing into the fallopian tube (white arrow).
Figure 5. Laparoscopic image. White arrow shows gestational sac.
On the other hand, recent evidence has demonstrated that 
rupture in an interstitial pregnancy always occurs before 12 
weeks.1 Other forms of ectopic pregnancy present similar rup-
ture time ranges, namely, seven to nine weeks.9 In two reports 
relating to interstitial pregnancy, it was concluded that the aver-
age gestation periods at the time of the diagnosis were 6.9 ± 0.3 
weeks1 and 8 ± 2 weeks,10 respectively. These findings were simi-
lar to what was reported from a prospective study on 119 cases 
of ectopic pregnancy that were not interstitial (6.8 to 8.8 weeks 
gestation).11
The patient whose case is reported here had undergone 
uterine surgery and appendectomy because of endometrio-
sis: both of these were risk factors that supported investigating 
the possibility of an ectopic pregnancy. High-resolution trans-
vaginal ultrasonography is the primary method used to diag-
nose ectopic pregnancy, thus enabling diagnosis prior to uter-
ine rupture. Three-dimensional transvaginal ultrasonography 
has some advantages over two-dimensional transvaginal ultra-
sonography, in that it enables viewing of the cornual area of the 
uterus, which facilitates differentiation between an interstitial 
and a corneal gestational site.12-15
Early diagnosis makes conservative treatment with 
methotrexate feasible, which avoids the risks associated 
with surgical procedures and preserves reproductive func-
tions. Local or systemic administration of methotrexate, or 
a combination of the two, can be used. The course of treat-
ment most often used is one or two cycles of intramuscular 
injection of methotrexate. The success rates of local injec-
tion and of combined or systemic treatment vary between 
62.5 and 83%.1,2,16,17 Although many authors have recom-
mended a particular serum β-hCG concentration as a crite-
rion for proceeding with conservative treatment using meth-
otrexate, there is no consensus in the literature regarding 
the safety and expected outcome of this method.1 Generally, 
cases of interstitial pregnancy are associated with elevated 
serum β-hCG levels.7
Tulandi and Al-Jaroudi1 reported that in three patients for 
whom methotrexate treatment failed, the serum β-hCG lev-
els ranged from 600 to 13,420 mIU/ml. Given this wide range, 
serum β-hCG levels may not be a good predictive measure-
ment of success in clinical treatment for cases of interstitial 
pregnancy. In another study, the success rate of systemic meth-
otrexate treatment for interstitial pregnancy exceeded 80% 
in patients with serum β-hCG levels up to 106,634 IU/l, even 
when an embryonic heartbeat was present.18
The medical course of action in cases of interstitial preg-
nancy should always be personalized for each patient. Systemic 
treatment with methotrexate via single or multiple intramus-
cular injections is used in cases in which the embryo does not 
show cardiac activity. It is interesting to note that methotrexate 
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treatment diminishes the proliferation of the trophoblast, even 
though it fails to cause embryonic death.2 When cardiac activity 
is observed, the recommended treatment is an intra-amniotic 
injection of potassium chloride and methotrexate, guided by 
transvaginal ultrasonography.1,7,13 In the case reported here, the 
initial treatment chosen was a single intramuscular injection of 
methotrexate. This treatment has the advantages of generally 
being highly effective, not causing any side effects and avoiding 
possible complications associated with a surgical procedure.18 
One week after the initial dose, the patient’s serum β-hCG con-
centration had decreased by over 15%, which is considered to 
be sufficient decline on the seventh day after treatment.7 Never-
theless, transvaginal ultrasonography examination detected an 
embryo with cardiac activity.
A second dose of methotrexate is recommended when 
serum β-hCG levels do not decrease properly. In a review on 
20 cases, a second dose was required in 30% of them, with a 
success rate of 94%.18 After conservative treatment with metho-
trexate, it is necessary to continue making regular examinations 
on the patient, because of the risk of rupture, and to measure 
serum β-hCG levels to assess whether the treatment was suc-
cessful. Serially repeated transvaginal ultrasonographic exam-
inations are not necessary, since the differences that can be 
detected in such examinations are not indicative of, or able to 
predict, treatment failure.18,19 
Nevertheless, the evidence of embryonic cardiac activity one 
week after the initial treatment, despite a significant decrease in 
serum β-hCG levels, showed that one follow-up transvaginal 
ultrasonographic examination was indispensable in our case. 
In the present case, the option of repeating the systemic dose 
was chosen, with a follow-up transvaginal ultrasonography, in 
the hope that embryonic cardiac activity would cease spontane-
ously. This approach has been shown to be successful in other 
cases described previously in the literature.1,13 
When embryonic cardiac activity is present, local injection 
of 2 mEq/ml potassium chloride with 1 mg/kg of methotrexate 
into the gestational sac, guided by transvaginal ultrasonogra-
phy, produces good results.1,2,7,20,21 Although a local injection is 
relatively safe and effective, it does require extensive technical 
training and experience. The cornual region is highly vascu-
larized and there is a risk of a puncture-related hemorrhage.9 
Additionally, some authors have reported side effects in more 
than 40% of patients treated with multiple doses.22 
Regarding surgical treatment, the most notable immediate 
risk is hemorrhage during surgical manipulation of the myo-
metrial tissue.1,13 Considering that, in the present case, embry-
onic cardiac activity persisted even after the second treatment 
with methotrexate, the risks and benefits of a local injection 
of potassium chloride and methotrexate and the option of lap-
aroscopy were discussed with the couple. The couple opted for 
minimally invasive video laparoscopic surgery. This procedure 
preserves the patient’s fertility and also enables fast recovery 
that allows the patient to resume regular activities quickly. In 
the present case, it is possible that the successful laparoscopic 
resection with minimal blood loss that was achieved can be 
attributed to the preceding treatment with methotrexate, 
which had attenuated trophoblast development.23 Treatment 
of interstitial pregnancy using methotrexate in conjunction 
with embolization of the uterine arteries, with transcervical 
suction under laparoscopic and hysteroscopic guidance and 
with dactinomycin as second-line chemotherapy has also been 
reported recently.24-28 
The most appropriate treatment for interstitial pregnancy 
remains undefined and always requires individualization for 
each patient. The choice of treatment will depend on the initial 
serum β-hCG levels and whether an embryo is present, as well 
as the local resources available and the experience of the medi-
cal team. Depending on each patient’s clinical profile, and pro-
vided that there is no imminent risk of rupture, treatment with 
methotrexate can be considered as a first line of treatment. It 
should, however, be followed by ultrasonographic examination. 
The decline in serum β-hCG levels cannot be used as the sole 
measurement of success, since it does not guarantee involution 
of the pregnancy. Video laparoscopy remains a safe and efficient 
treatment option for interstitial pregnancy when pharmacolog-
ical treatment is unsuccessful.
Since occurrences of interstitial pregnancy are rare and 
the options for treatment decisions remain open, we carried 
out a review of the literature in order to complete this report. 
In PubMed, we searched for the term “pregnancy, ectopic” in 
the medical subject headings, and the term “interstitial” in all 
words. The date range for this search was from July 31, 2005, 
to July 30, 2010, in the English or Portuguese languages. In 
Lilacs (Literatura Latino-Americana e do Caribe em Ciências 
da Saúde), we searched for the term “gravidez ectópica” in the 
subject and “intersticial” in all words. The date range for this 
search covered five years prior to July 30, 2010. In the Cochrane 
Library, we searched for the expression “interstitial pregnancy”. 
The date range for this search covered five years prior to July 
30, 2010. In the Embase database, we searched for the expres-
sion “interstitial pregnancy” in “all fields”. The date range for 
this search covered five years prior to February 23, 2011. 
In PubMed, we found 55 papers, and 20 of them related 
directly to treatment. In Lilacs, we found only one paper (in 
Portuguese), which had already been selected from the PubMed 
database.7 In the Cochrane Library, we found seven references, 
which all dealt with other types of ectopic pregnancy. In the 
Embase databases, we found 45 references. Four of these were 
directly pertinent to our study: two case reports,23,24 one pro-
spective study22 and one review.7 This last review had already 
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been selected from the PubMed database. A descriptive sum-
mary of these searches is presented in Table 1.
Since interstitial pregnancy is a rare form of ectopic preg-
nancy, conducting a randomized study would be problematic. 
Hence, case studies documenting the experiences of different 
medical teams are important, since they facilitate future reviews 
of the evidence and add to the medical knowledge base perti-
nent to this condition. Thus, documentation of more cases will 
enable analysis across cases and aid in establishing improved 
medical practices.
CONCLUSION
In the case presented here, methotrexate was not effective for 
treating an interstitial pregnancy. Persistent embryonic cardiac 
activity indicated a second dose, without success. Resection was 
done successfully using video laparoscopy.
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